[go: up one dir, main page]

NO924926L - TRANSDERMAL ADMINISTRATION OF BUPRENORPHINE - Google Patents

TRANSDERMAL ADMINISTRATION OF BUPRENORPHINE

Info

Publication number
NO924926L
NO924926L NO92924926A NO924926A NO924926L NO 924926 L NO924926 L NO 924926L NO 92924926 A NO92924926 A NO 92924926A NO 924926 A NO924926 A NO 924926A NO 924926 L NO924926 L NO 924926L
Authority
NO
Norway
Prior art keywords
buprenorphine
transdermal administration
administration
enhancer
cra2
Prior art date
Application number
NO92924926A
Other languages
Norwegian (no)
Other versions
NO924926D0 (en
Inventor
Kuldeepak Sharma
Samir D Roy
Eric J Roos
Original Assignee
Cygnus Therapeutic Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/540,908 external-priority patent/US5069909A/en
Application filed by Cygnus Therapeutic Systems filed Critical Cygnus Therapeutic Systems
Publication of NO924926D0 publication Critical patent/NO924926D0/en
Publication of NO924926L publication Critical patent/NO924926L/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Fremgangsmåte og laminert kompositt for administrering av buprenorfin transdermalt for å behandle smerte. Komposltten omfatter et ugjennomtrengelig baklag og et reservoarlag som inneholder buprenorfin og eventuelt en gjennomtrengningsforøker kombinert med et trykk- sensitivt adhesiv og med mengder buprenorfin og eventuell forøker som er tilstrekkelig til å forårsake at buprenorfin passerer gjennom huden ved en hastighet som er over ca. 0,05 >jg/cra2/t.Method and laminated composite for the administration of buprenorphine transdermally to treat pain. The composite comprises an impermeable backing and a reservoir layer containing buprenorphine and optionally a permeation enhancer combined with a pressure sensitive adhesive and with amounts of buprenorphine and any enhancer sufficient to cause buprenorphine to pass through the skin at a rate greater than ca. 0.05> µg / cra2 / t.

NO92924926A 1990-06-20 1992-12-18 TRANSDERMAL ADMINISTRATION OF BUPRENORPHINE NO924926L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/540,908 US5069909A (en) 1990-06-20 1990-06-20 Transdermal administration of buprenorphine
PCT/US1991/004189 WO1991019474A1 (en) 1990-06-20 1991-06-12 Transdermal administration of buprenorphine

Publications (2)

Publication Number Publication Date
NO924926D0 NO924926D0 (en) 1992-12-18
NO924926L true NO924926L (en) 1993-02-04

Family

ID=26783205

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924926A NO924926L (en) 1990-06-20 1992-12-18 TRANSDERMAL ADMINISTRATION OF BUPRENORPHINE

Country Status (1)

Country Link
NO (1) NO924926L (en)

Also Published As

Publication number Publication date
NO924926D0 (en) 1992-12-18

Similar Documents

Publication Publication Date Title
AU533491B2 (en) Bandage for administering drugs to the skin
MY103740A (en) Transdermal therapeutic system
NO940590L (en) Transdermal administration of benzodiazepines with short or medium half-lives
CA2064687A1 (en) Method and device for administering dexmedetomidine transdermaly
DK0697860T3 (en) Estradiol-containing transdermal therapeutic system
IL124279A (en) Transdermal therapeutic systems containing hmg-coa reductase inhibitors
DK0973497T3 (en) Pharmaceutical carrier suitable for delivery of pharmaceutical compounds to mucosal surface
IE46069L (en) Adhesive skin patch
ZA951427B (en) Drug containing adhesive composite transdermal delivery device
GR3036144T3 (en) Transdermal delivery device
PL335410A1 (en) Medium for transcutaneous testosterone administration
DE69923348D1 (en) TRANSDERMAL MEDICINE ADMINISTRATION SYSTEM
DE69916492D1 (en) PLASTER FOR THE TRANSDERMAL APPLICATION OF VOLATILE, LIQUID ACTIVE SUBSTANCES
EP0138551A3 (en) A system for the transdermal delivery of nitroglycerin
PL307786A1 (en) Plaster for percutaneous administration of systemically acting steroid hormones
HRP930991A2 (en) Transdermal therapeutic system containing the active tance 17-beta-oestradiol and the process for the production eof
CA2183960C (en) Medicinal patches for percutaneous administration
MXPA02009103A (en) Transdermal therapeutic system for the delivery of lerisetron.
NO924926L (en) TRANSDERMAL ADMINISTRATION OF BUPRENORPHINE
LV10749A (en) Transdermal therapeutic system for the application of physostigmine to the skin and its manufacturing tolerance
MY113222A (en) Medicinal patches for percutaneous administration
PL319013A1 (en) Transdermal therapeutic system containing estradiol and water bonding additives
PT84278A (en) Dermal and transdermal patches having a discontinuous pattern adhesive layer
MX9704291A (en) Transdermal delivery system with adhesive overlay and peel seal disc.